FDA OKs Injectable Semaglutide for Chronic Weight Management

(MedPage Today) -- The FDA approved Novo Nordisk's injectable semaglutide (Wegovy) for adults with obesity or overweight, the agency announced Friday.
The GLP-1 receptor was approved for chronic weight management in adults with obesity (BMI of...